KERAFAST, INC. Non-Antibody Products — page 12 of 15
Non-Antibody Products
Page 12 of 15
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| PA-3M Cys (Anthrax Protective Mutant Antigen (PA-3M Cys)) | Purified by: Hydroxyapatite Chromatography. | 100ug (2.4mg/mL) | ENH005-LT | More Info |
| PA-3M-SoSi-H6 (Anthrax Protective Mutant Antigen (PA-3M-SoSi-H6)) | Purified by: Hydroxyapatite Chromatography. | 100ug (8.08mg/mL) | ENH012-LT | More Info |
| PA-U7 (Anthrax Protective Mutant Antigen (PA-U7)) | Purified by: S200 Size Exclusion Chromatography. | 100ug (7.47mg/mL) | ENH006-LT | More Info |
| PA-U7-K562C (Anthrax Protective Mutant Antigen (PA-U7-K562C)) | Purified by: Hydroxyapatite Chromatography. | 100ug (3.27mg/mL) | ENH010-LT | More Info |
| PGC-1α Expressing HEK-293T/17 Cell Line (293T-PGC) | Source: Human Embryonic kidney. Cell type: HEK 293T / 17 (ATCC #CRL-11268). | 1 vial | ENH069-FP | More Info |
| Photoactivatable Serotonin (BHQ-O-5HT) | Purity: >95%, HPLC. MW: 574.11 | 3mg | EGA012 | More Info |
| Photo-BAPTA, Tetramethyl Ester | Purity: >98% 1HNMR. MW: 674.69 | 25mg | EGA257 | More Info |
| Photocleavable Alpha-Factor for Yeast | Synthetic. Purity: >90%. LC / MS. MW: MW = 1799.96 g / mol, FW (TFA salt)… | 200uL (1mM) | EPD001 | More Info |
| Photo-DIBO-EG4-SH | Purity: >98% 1HNMR. MW: 512.66 | 40mg (20mg/mL in DMSO) | EGA260 | More Info |
| Photo-ODIBO-EG4-NHS | Purity: >99% 1HNMR. MW: 623.65 | 25mg | EGA258 | More Info |
| p-Hydroxybenzoic Acid (bio-derived) | Purity: >98%, HPLC. MW: 138.12 g / mol | 1g | ESP002 | More Info |
| p-Hydroxybenzoic Acid (bio-derived) | Purity: >98%, HPLC. MW: 138.12 g / mol | 5g | ESP003 | More Info |
| PKR KO (C57) Macrophage Cell Line | Source: Mouse Bone Marrow. Cell type: Macrophage. | 1 vial | ENH181-FP | More Info |
| PMS-2 Null/Lambda-LIZ Transgene Transformed MEF Cell Line (127TAg) | Source: Mouse embryo. Cell type: Transformed MEF. | 1 vial | ENH118-FP | More Info |
| Poly(1,8-carbazole)-benzothiadiazole copolymer (PCzBT) Nanoparticles | n/a | 1mL | EKA002 | More Info |
| Poly(1,8-carbazole)-dithienylbenzothiadiazole copolymer (PCzDTBT) Nanoparticles | n/a | 1mL | EKA003 | More Info |
| Poly(dithiazolfluorene-alt-thiadiazolobenzotriazole) (PSN) Nanoparticles | n/a | 1mL | EKA001 | More Info |
| poly(GMA-ran-OEGMA) | MW: 2.5x10^6 g / mol | 100mg | EGA697 | More Info |
| poly(GMA-ran-OEGMA)-Lysozyme Conjugate | n/a | 50ug | EGA698 | More Info |
| Polyphosphate, Long Chain (p700) | Purity: <1% monophosphate. MW: Heterogeneous; Number average ~113 kDa; Ran… | 100mg | EUI002 | More Info |
| Polyphosphate, Long Chain (p700) | Purity: <1% monophosphate. MW: Heterogeneous; Number average ~113 kDa; Ran… | 200mg (2 x 100mg) | EUI003 | More Info |
| Polyphosphate, Long Chain (p700) | Purity: <1% monophosphate. MW: Heterogeneous; Number average ~113 kDa; Ran… | 500mg (5 x 100mg) | EUI004 | More Info |
| Polyphosphate, Medium Chain (p100) | Purity: <1% monophosphate. MW: Heterogeneous; Number average ~11.5 kDa; Ra… | 100mg | EUI005 | More Info |
| Pre-Formed Fibrils, A53T α-Synuclein (α-syn-A53T PFFs) | Source: Human, expressed in E. coli BL21 (DE3) CP+. Purity: >95 %, purifie… | 1mg | EGP014 | More Info |
| Pre-Formed Fibrils, E46K α-Synuclein (α-syn-E46K PFFs) | Source: Human, expressed in E. coli BL21 (DE3) CP+. Purity: >95 %, purifie… | 1mg | EGP016 | More Info |
| Pre-Formed Fibrils, WT α-Synuclein (α-syn-WT PFFs) | Source: Human, expressed in E. coli BL21 (DE3) CP+. Purity: >95 %, purifie… | 1mg | EGP018 | More Info |
| Prostate Cancer Cell Line (CWR-R1-AD1) | Source: Human Prostate. Cell type: Prostate Cancer. | 1 vial | EMN024-FP | More Info |
| Prostate Cancer Cell Line (CWR-R1-D567) | Source: Human Prostate. Cell type: Prostate Cancer. | 1 vial | EMN028-FP | More Info |
| Prostate Cancer Cell Line (CWR-R1-I567) | Source: Human Prostate. Cell type: Prostate Cancer. | 1 vial | EMN029-FP | More Info |
| Prostate Cancer Cell Line (22Rv1-undup1) | Source: Human Prostate. Cell type: Prostate Cancer. | 1 vial | EMN025-FP | More Info |
| Prostate Cancer Cell Line (22Rv1-undup2) | Source: Human Prostate. Cell type: Prostate Cancer. | 1 vial | EMN026-FP | More Info |
| Prostate Cancer Cell Line (22Rv1-undup3) | Source: Human Prostate. Cell type: Prostate Cancer. | 1 vial | EMN027-FP | More Info |
| Pseudotyped Δ-G/CHIKV-E-NLucP rVSV | n/a | 0.5mL (≥ 10^6 IU/mL) | EGA316-PM | More Info |
| Pseudotyped ΔG-DsRed (G*ΔG-DsRed) rVSV | n/a | 300uL | EH1018-PM | More Info |
| Pseudotyped ΔG-DsRed (G*ΔG-DsRed) rVSV w/ pCAGGS-G-Kan | n/a | 300uL; w/ pCAGGS-G-Kan | EH1023-PM | More Info |
| Pseudotyped Δ-G/EBOV-GP-NLucP rVSV | n/a | 0.5mL (≥ 10^6 IU/mL) | EGA297-PM | More Info |
| Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSV | n/a | 300uL | EH1019-PM | More Info |
| Pseudotyped ΔG-GFP (G*ΔG-GFP) rVSVw/ pCAGGS-G-Kan | n/a | 300uL; w/ pCAGGS-G-Kan | EH1024-PM | More Info |
| Pseudotyped Δ-G/LASV-GP-NLucP rVSV | n/a | 0.5mL (≥ 10^6 IU/mL) | EGA299-PM | More Info |
| Pseudotyped ΔG-luciferase (G*ΔG-luciferase) rVSV | n/a | 300uL | EH1020-PM | More Info |
| Pseudotyped ΔG-luciferase (G*ΔG-luciferase) rVSVw/ pCAGGS-G-Kan | n/a | 300uL; w/ pCAGGS-G-Kan | EH1025-PM | More Info |
| Pseudotyped Δ-G/SARS-CoV-2-S_D614Gd21-NLucP rVSV | n/a | 0.5mL (≥ 10^6 IU/mL) | EGA298-PM | More Info |
| Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV | n/a | 300uL | EH1035-PM | More Info |
| Pseudotyped ΔG-SEAP (G*ΔG-SEAP) rVSV w/ pCAGGS-G-Kan | n/a | 300uL; w/ pCAGGS-G-Kan | EH1036-PM | More Info |
| Pseudotyped Δ-G/VSV-G-NLucP rVSV | n/a | 0.8mL (≥ 10^7 IU/mL) | EGA317-PM | More Info |
| P2Y1 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y1) | Source: Human Glial Cell. Cell type: Glioblastoma. | 1 vial | ENC018 | More Info |
| P2Y11 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y11) | Source: Human Glia Cell. Cell type: Glioblastoma. | 1 vial | ENC022 | More Info |
| P2Y12 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y12) | Source: Human Glia Cell. Cell type: Glioblastoma. | 1 vial | ENC023 | More Info |
| P2Y4 Expressing Human Astrocytoma Cell Line (1321N1-HA-P2Y4) | Source: Human Glia Cell. Cell type: Glioblastoma. | 1 vial | ENC020 | More Info |
| Quinic Acid | Purity: >97% 1H NMR. MW: 192.17 g / mol | 1g | ESP005 | More Info |
KERAFAST, INC.
KERAFAST, INC.
An Absolute Biotech Company
2 Shaker Road, Unit B101
Shirley MA 01464
P: +1-617-336-3228
P: +1-800-546-1760
F: +1-866-727-9826
info@kerafast.com
Tech Support: TechnicalSupport@kerafast.com
https://www.kerafast.com
Return to Profile